Results 1 to 10 of about 54,569 (245)

Severity of Functional Mitral Regurgitation on Admission for Acute Decompensated Heart Failure Predicts Long‐Term Risk of Rehospitalization and Death [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Functional mitral regurgitation (FMR) has emerged as a therapeutic target in patients with chronic heart failure and left ventricular systolic dysfunction. The significance of FMR in acute decompensated heart failure remains obscure.
Rachna Kataria, Francesco Castagna, Shivank Madan, Paul Kim, Omar Saeed, Yaw A. Adjepong, Angelos A. Melainis, Cynthia Taub, Mario J. Garcia, Azeem Latib, Ulrich P. Jorde   +10 more
doaj   +2 more sources

SGLT2 inhibitors in acute decompensated heart failure, what do we know?

Терапевтический архив, 2022
The current worldwide prevalence of heart failure is growing, while its combination with cardiovascular and other conditions determines a poor prognosis in these patients.
Anastasiya E. Lapteva, Svetlana N. Nasonova, Igor V. Zhirov, Sergey N. Tereshchenko   +3 more
doaj   +3 more sources

The Importance of Hyperthyroid Screening in Acute Decompensated Heart Failure with Persistent Tachycardia Despite Optimal Decongestion: A Case Report

Majalah Kardiologi Indonesia, 2023
Background: Hyperthyroid has various effects on the cardiovascular system. Cardiac arrhythmias ranging from sinus tachycardia to atrial fibrillation and low/high cardiac output state to congestive heart failure are observed in patients with ...
Matthew Aldo Wijayanto, Risalina Myrtha, Nurhasan Agung Prabowo   +2 more
doaj   +3 more sources

Acute Kidney Disease After Acute Decompensated Heart Failure [PDF]

Kidney International Reports, 2022
Introduction: Acute kidney disease (AKD) represents a continuum of kidney injury for 7 to 90 days after acute kidney injury (AKI). The incidence and prognosis of AKD after acute decompensated heart failure (ADHF) are currently unclear.
Jia-Jin Chen, Tao-Han Lee, George Kuo, Chieh-Li Yen, Shao-Wei Chen, Pao-Hsien Chu, Pei-Chun Fan, Victor Chien-Chia Wu, Chih-Hsiang Chang   +8 more
doaj   +3 more sources

Acute decompensated heart failure: current pharmacological approaches

Research Reports in Clinical Cardiology, 2014
Domingo A Pascual-Figal, Francisco Pastor-Perez, Luis Caballero, Iris P Garrido, Maria Teresa Perez-MartinezCardiology Department, Virgen de la Arrixaca University Hospital, School of Medicine, University of Murcia, Murcia, SpainAbstract: Acute heart ...
Pascual-Figal DA, Pastor-Perez F, Caballero L, Garrido IP, Perez-Martinez MT   +4 more
doaj   +3 more sources

Acute Decompensated Heart Failure [PDF]

Critical Care Clinics, 2007
This article defines acute decompensated heart failure. Additionally, it lists common precipitating factors and the clinical presentation. Proper diagnostic technique is highlighted, as are possible treatments.
James F, Neuenschwander, Ragavendra R, Baliga   +1 more
  +8 more sources

Acute Decompensated Heart Failure

Cardiology Clinics, 2012
Acute decompensated heart failure (ADHF) is the most common cause of cardiovascular hospital admission; 1 in 4 patients with heart failure is readmitted within 30 days of being discharged, and ADHF consumes 1% to 2% of the total health care resources.
Jennifer R, Brown, Stephen S, Gottlieb
  +9 more sources

Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.

PLoS ONE, 2021
BackgroundAdmission systolic blood pressure has emerged as a predictor of postdischarge outcomes of patients with acute decompensated heart failure; however, its validity in varied clinical conditions of this patient subset is unclear.
Yuichi Kawase, Takao Kato, Takeshi Morimoto, Reo Hata, Ryosuke Murai, Takeshi Tada, Harumi Katoh, Kazushige Kadota, Erika Yamamoto, Hidenori Yaku, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Yusuke Yoshikawa, Moritake Iguchi, Kazuya Nagao, Yukihito Sato, Koichiro Kuwahara, Takeshi Kimura   +18 more
doaj   +1 more source

Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background It remains unclear whether beta‐blocker use at hospital admission is associated with better in‐hospital outcomes in patients with acute decompensated heart failure.
Yodo Tamaki, Hidenori Yaku, Takeshi Morimoto, Yasutaka Inuzuka, Neiko Ozasa, Erika Yamamoto, Yusuke Yoshikawa, Makoto Miyake, Hirokazu Kondo, Toshihiro Tamura, Takeshi Kitai, Moritake Iguchi, Kazuya Nagao, Ryusuke Nishikawa, Yuichi Kawase, Takashi Morinaga, Mitsunori Kawato, Mamoru Toyofuku, Yukihito Sato, Koichiro Kuwahara, Yoshihisa Nakagawa, Takao Kato, Takeshi Kimura   +22 more
doaj   +1 more source

Acute Decompensated Heart Failure Update [PDF]

Current Cardiology Reviews, 2014
Acute decompensated heart failure (ADHF) continues to increase in prevalence and is associated with substantial mortality and morbidity including frequent hospitalizations. The American Heart Association is predicting that more than eight million Americans will have heart failure by 2030 and that the total direct costs associated with the disease will ...
Teerlink, John R, Alburikan, Khalid, METRA, Marco, Rodgers, Jo E.   +3 more
openaire   +3 more sources